Baxter International Inc (BAX): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2012-12-31, 2013-12-31, 2021-12-31, 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$7.87B
Year ended 2025-12-31
$8.02B
Trailing 12 months to 2026-06-30
+6.5%
3-year compound annual growth
2007-12-31: $5.74B2008-12-31: $6.22B2009-12-31: $6.04B2010-12-31: $6.88B2011-12-31: $6.85B2012-12-31: $6.80B2013-12-31: $5.25B2014-12-31: $6.14B2015-12-31: $5.82B2016-12-31: $6.05B2017-12-31: $6.11B2018-12-31: $6.34B2019-12-31: $6.60B2020-12-31: $7.09B2021-12-31: $7.43B2022-12-31: $6.51B2023-12-31: $6.21B2024-12-31: $6.65B2025-12-31: $7.87B$7.87B
2007-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$7.87B+18.2%2026-02-12, From 2025-01-01
2024-12-31$6.65B+7.1%2026-02-12, From 2024-01-01
2023-12-31$6.21B-4.6%2026-02-12, From 2023-01-01
2022-12-31$6.51Bn/c2025-02-21, From 2022-01-01
2021-12-31$7.43Bn/c2024-02-08, From 2021-01-01
2020-12-31$7.09B+7.3%2023-02-09, From 2020-01-01
2019-12-31$6.60B+4.1%2022-02-23, From 2019-01-01
2018-12-31$6.34B+3.8%2021-02-11, From 2018-01-01
2017-12-31$6.11B+1.0%2020-03-17, From 2017-01-01
2016-12-31$6.05B+3.9%2019-02-21, From 2016-01-01
2015-12-31$5.82B-5.1%2018-02-23, From 2015-01-01
2014-12-31$6.14B+16.9%2017-02-23, From 2014-01-01
2013-12-31$5.25Bn/c2016-02-26, From 2013-01-01
2012-12-31$6.80Bn/c2015-02-26, From 2012-01-01
2011-12-31$6.85B-0.6%2014-02-21, From 2011-01-01
2010-12-31$6.88B+14.0%2013-02-21, From 2010-01-01
2009-12-31$6.04B-2.9%2012-02-23, From 2009-01-01
2008-12-31$6.22B+8.3%2011-02-23, From 2008-01-01
2007-12-31$5.74Bn/a2010-02-23, From 2007-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Baxter International Inc (BAX)2025-12-31$7.87B+18.2%
Boston Scientific Corp (BSX)2025-12-31$6.22B+18.3%
Becton Dickinson & Co (BDX)2025-09-30$11.91B+7.8%
ResMed Inc (RMD)2026-06-30$2.20B+5.3%
3M Co (MMM)2025-12-31$14.99B+3.8%
Stryker Corp (SYK)2025-12-31$9.05B+11.0%
Dexcom Inc (DXCM)2025-12-31$1.86B+16.6%
Medline Inc. (MDLN)2025-12-31$20.91B+12.9%
MiniMed Group, Inc. (MMED)2026-04-24$1.42B+19.8%

Compare BAX, BSX, BDX, RMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗